NASDAQ:CHNA Loncar China Biopharma ETF (CHNA) Price, Holdings, & News → The system that called 2023’s top 7 stocks is at it again… (From WealthPress) (Ad) Free CHNA Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$13.53▼$13.5350-Day Range$13.53▼$14.7752-Week Range$13.35▼$22.89Volume100 shsAverage Volume538 shsMarket Capitalization$19.35 millionAssets Under Management$3.74 millionDividend Yield0.44%Net Expense Ratio0.79% Stock AnalysisStock Analysis Get Loncar China Biopharma ETF alerts: Email Address About Loncar China Biopharma ETF (NASDAQ:CHNA)The Loncar China BioPharma ETF (CHNA) is an exchange-traded fund that is based on the Loncar China BioPharma index. The fund tracks a tier-weighted index of companies directly involved in the growth of Chinas pharmaceutical and biotech industry. CHNA was launched on Aug 14, 2018 and is managed by Loncar.Read More Ad Wealthpin ProOne trade. One ticker. One week. Do you want to target weekly income of up to $2k or more… Starting with just $500... With just one trade per week? Well, then you should click here to see this free training. CHNA ETF News HeadlinesFebruary 6, 2024 | investing.comMiraeAsset TIGER China Biotech Solactive ETF (371470)January 20, 2024 | investing.comChina Southern CSI Cmunctn Srvcs ETF (159511)April 23, 2024 | Wealthpin Pro (Ad)One trade. One ticker. One week. Do you want to target weekly income of up to $2k or more… Starting with just $500... With just one trade per week? December 30, 2023 | nasdaq.comThis ETF Has Depth Needed for China ReboundDecember 21, 2023 | money.usnews.comChina Bans Export of Rare Earths Processing TechnologiesDecember 19, 2023 | msn.comChina Sinochem Buys Rare Venezuelan Oil Cargo After U.S. Suspends Sanctions - SourcesDecember 16, 2023 | investing.comChina Universal Nasdaq 100 ETF (QDII) (159660)December 13, 2023 | investing.comAmundi MSCI China A II ETF (C024)April 23, 2024 | Wealthpin Pro (Ad)One trade. One ticker. One week. Do you want to target weekly income of up to $2k or more… Starting with just $500... With just one trade per week? December 12, 2023 | investing.com2823 ETF Stock Price HistorySee More Headlines Receive CHNA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Loncar China Biopharma ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerExchange Traded Concepts Fund NameLoncar China Biopharma ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:CHNA Inception Date8/14/2018 Fund ManagerDenise M. Krisko, Habib Moudachirou WebN/A Phone14089961010Fund Focus Asset ClassEquity BenchmarkLoncar China BioPharma Index CategorySector FocusHealth Care Development LevelEmerging Markets RegionAsia-Pacific Number of Holdings89 Fund Statistics Assets Under Management$3.74 million Average Daily Volume$1,200.80 Discount/Premium-0.06% Administrator, Advisor and Custodian AdministratorU.S. Bancorp Fund Services, LLC AdvisorExchange Traded Concepts, LLC CustodianU.S. Bank, N.A. DistributorQuasar Distributors, LLC Transfer AgentU.S. Bank, N.A. TrusteeN/A Lead Market MakerGTS Miscellaneous Outstanding Shares1,430,000Beta0.67 Creation Unit50,000 Creation Fee$750.00 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report Ad Wealthpin ProOne trade. One ticker. One week. Do you want to target weekly income of up to $2k or more… Starting with just $500... With just one trade per week? Well, then you should click here to see this free training. Loncar China Biopharma ETF ExpensesTypeCHNAHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.79%0.56%0.54%0.48%0.51%Other Expenses0.00%0.40%0.54%0.34%0.58%Total Expense0.79%0.72%0.70%0.58%0.70%Fee Waiver0.00%-0.53%-0.55%-0.22%-0.57%Net Expense0.79%0.60%0.60%0.54%0.58% Loncar China Biopharma ETF (CHNA) HoldingsTop 10 CHNA HoldingsGeron(NASDAQ:GERN)Holding Weight: 2.78%Acrivon Therapeutics(NASDAQ:ACRV)Holding Weight: 2.54%Enliven Therapeutics(NASDAQ:ELVN)Holding Weight: 2.20%Janux Therapeutics(NASDAQ:JANX)Holding Weight: 1.82%Nuvation Bio(NYSE:NUVB)Holding Weight: 1.75%2seventy bio(NASDAQ:TSVT)Holding Weight: 1.67%Revolution Medicines(NASDAQ:RVMD)Holding Weight: 1.54%Prelude Therapeutics(NASDAQ:PRLD)Holding Weight: 1.50%Lyell Immunopharma(NASDAQ:LYEL)Holding Weight: 1.48%Adicet Bio(NASDAQ:ACET)Holding Weight: 1.45%Full Holdings Details Similar ETFsProShares UltraShort Nasdaq BiotechnologyNASDAQ:BISJPMorgan Healthcare Leaders ETFNASDAQ:JDOCHorizon Kinetics Medical ETFNASDAQ:MEDXFirst Trust Nasdaq Pharmaceuticals ETFNASDAQ:FTXHInvesco Nasdaq Biotechnology ETFNASDAQ:IBBQ CHNA ETF - Frequently Asked Questions How often does Loncar China Biopharma ETF pay dividends? What is the dividend yield for Loncar China Biopharma ETF? Loncar China Biopharma ETF announced an annual dividend on Friday, October 13th. Stockholders of record on Tuesday, October 17th will be given a dividend of $0.0674 per share on Wednesday, October 18th. The ex-dividend date is Monday, October 16th. Read our dividend analysis for CHNA. What does CHNA invest in? Loncar China Biopharma ETF is a equity fund issued by Exchange Traded Concepts. CHNA focuses on health care investments and follows the Loncar China BioPharma Index. The fund's investments total to approximately $3.74 million assets under management. What stocks does Loncar China Biopharma ETF hold? CHNA invests in 89 holdings. Some of the stocks in their portfolio include Geron (GERN), Acrivon Therapeutics (ACRV), Enliven Therapeutics (ELVN), Janux Therapeutics (JANX), Nuvation Bio (NUVB), 2seventy bio (TSVT), Revolution Medicines (RVMD), Prelude Therapeutics (PRLD), Lyell Immunopharma (LYEL) and Adicet Bio (ACET). What is the management fee for Loncar China Biopharma ETF? Loncar China Biopharma ETF's management fee is 0.79% and has no other recorded expenses or fee waivers. The net expense ratio for CHNA is 0.79%. What other stocks do shareholders of Loncar China Biopharma ETF own? Based on aggregate information from My MarketBeat watchlists, some companies that other Loncar China Biopharma ETF investors own include Baidu (BIDU), Salesforce (CRM), Capcom (CCOEY), Alibaba Group (BABA), Activision Blizzard (ATVI), ArcBest (ARCB), Advanced Micro Devices (AMD) and Analog Devices (ADI). This page (NASDAQ:CHNA) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersPentagon contract could send this $2 AI stock soaringBehind the MarketsThe A.I. story nobody is telling you (Read ASAP)TradeSmithHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsIncredible Opportunity to Retire FAST!Crypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Loncar China Biopharma ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.